Issue link: https://nebusinessmedia.uberflip.com/i/676047
www.wbjournal.com May 9, 2016 • Worcester Business Journal 21 technology in their blood-glucose monitoring tests. "It has enormous potential benefits in regions of the world where diagnosing early can cause public health officials to prevent a spread," McQuilken said. Corporate partners A global presence on the lateral flow market is Germany-based Siemens Healthcare, a longtime partner of Web Industries in various segments of the medical market. Peter Janeczek, director strategic procurement, point of care, at Siemens Healthcare, said LFI tests are some of the fastest-growing products at Siemens. "It offers quick, reliable [results] with very little patient sample, and no sample preparation," Janeczek said. "Many of these factors are differentiators from other diagnostic tests in the marketplace and allow our healthcare customers to focus less on testing and focus more on patient care." Newest player About four years ago, Web Industries launched a task force to figure out how it could expand its operations and lead the charge on a technology that is in high demand. They found that opportunity in LFI device manufacturing and production, Batley said. "These are the types of tests, these are the types of platforms that are going to provide the ease of diagnostics that might have taken hours, days, weeks for analysis that can now be done at the point of application," he said. The new 6,500-square-foot manufacturing facility has commercial- scale biochemistr y laborator y capabilities, automated reel-to-reel device production, device assembly, packaging and private labelling. Web Industries is the only non-competing medical contract manufacturer in the U.S. to offer reel-to-reel strip manufacturing, device assembly and packaging services at commercial-level volumes, according to the company. The company received $150,000 in MLSC tax incentives for its commitment to hiring 10 new employees this year. It could add up to 40 employees as a result of the new center. The facility has the potential to double in space, said Laurie Partridge, a company spokesperson. Location was a key factor when MLSC was deciding which companies should receive tax incentives, McQuilken said. MLSC made sure several of the receiving companies were located outside of Boston and Cambridge. The MetroWest region is a hotbed of life sciences growth, he said. Over the past three years, the city of Marlborough alone added 6,000 jobs, two-thirds of which were in life sciences. "The benefit of Web Industries increasing its capacity in manufacturing in space is that companies developing those technologies will be able to manufacture them here in Massachusetts," McQuilken said. n Looking to maximize the value of your privately owned business? Have questions and concerns on how to do it? At ROCG – a nationally recognized leader in the business exit/transition field – we have the answers. Our hands-on, best practices approach, ensures our clients implement successful plans to meet their personal lifestyle and legacy objectives, whether it be an outside third-party sale, management buy-out or a next generation family transfer. For more information, our White Paper on Business Transition, recent business exit and value growth articles and upcoming speaking engagements visit http://americas.rocg.com or contact Terry Shepherd at 617-412-4640. 617-412-4640 • http://americas.rocg.com Marlborough-based Web Industries celebrated the opening of its new 6,500-square-foot lateral flow immunoassay manufacturing facility on the site of its Web Boston plant in Holliston. P H O T O / L A U R A F I N A L D I